likely

Bybit x FXStreet TradFi Report: Japan’s Historic Leadership Shift Sparks Nikkei Rally and Yen Weakness

DUBAI, UAE , Oct. 10, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has released a new…

3 weeks ago

University of Phoenix College of Doctoral Studies Releases White Paper on Aligning AI Innovation With Human Potential

Author Dr. Jessica Sylvester examines the “productivity paradox” and offers human-centered strategies for AI adoption in the workplacePHOENIX--(BUSINESS WIRE)--University of…

4 weeks ago

DoubleLine Foresees Further Treasury Yield Curve Steepening, Risk of Elevated Term Premium

TAMPA, Fla., Oct. 3, 2025 /PRNewswire/ -- The U.S. Treasury yield curve, DoubleLine Global Bond Portfolio Manager Bill Campbell writes in a…

4 weeks ago

Strong Lamborghini SC63 pace goes unrewarded in the Battle on the Bricks at Indianapolis

#63 pairing of Mortara-Grosjean finish 10th in penultimate round of the year after late cautionSant’Agata Bolognese/Indianapolis, 21 September 2025 –…

1 month ago

EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts

PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today at the European Academy of Dermatology and Venereology (EADV)…

1 month ago

Huion Launches 2025 Back-to-School Deals: Promotions for Creative Tools for Students & Teachers

LOS ANGELES, Aug. 15, 2025 /PRNewswire/ -- With August here, the Back-to-School season is officially underway. Students, parents, and teachers…

3 months ago

Cornerstone VR Sponsors Muay Thai Athlete Gene Smith to Support Youth Empowerment and Combat Knife Crime

Tuesday 8 July, 2025 According to the Youth Endowment Fund’s Children, Violence and Vulnerability Report 5, children most vulnerable to…

4 months ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…

4 months ago